Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials

Project Information

chemos

Grant agreement ID: 727416

DOI 10.3030/727416

Project closed

EC signature date 23 September 2016

Start date 1 October 2016

End date 30 September 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 146 668,00

EU contribution € 146 668,00

Coordinated by

CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH
Austria

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

Author(s): Berend Snijder, Gregory I Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin, Lukas Kazianka, Johannes W Bigenzahn, Gregor Hoermann, Nicole Prutsch, Olaf Merkel, Anna Ringler, Monika Sabler, Georg Jeryczynski, Marius E Mayerhoefer, Ingrid Simonitsch-Klupp, Katharina Ocko, Franz Felberbauer,
Published in: The Lancet Haematology, 2017, ISSN 2352-3026
Publisher: Elsevier Limited
DOI: 10.1016/S2352-3026(17)30208-9

Intellectual Property Rights

Trademark (1)

(C)hemos

Application/Publication number: CM 004EUtm
Date: 2014-11-06

Patent (2)

MONOLAYER OF PBMCS OR BONE-MARROW CELLS AND USES THEREOF

Application/Publication number: PCT/EP 2015/072046
Date: 2015-09-24

MULTIWELL IMAGING PLATE AND METHOD FOR INCUBATING NON-ADHERENT CELLS

Application/Publication number: PCT/EP 2017/060561
Date: 2017-05-03